Astex Pharmaceuticals to Host Annual Analyst and Investor Day on March 27, 2012
DUBLIN, Calif.--(BUSINESS WIRE)--
Astex Pharmaceuticals, Inc. (NASDAQ:ASTX), a pharmaceutical company
dedicated to the discovery and development of novel small molecule
therapeutics, today announced its Annual Analyst and Investor Day will
take place from 10 am to 1 pm ET on Tuesday, March 27th in New York.
During this event, James S.J. Manuso, PhD, chairman and chief executive
officer, and Astex's management team will provide updates on the
Company's business, clinical and discovery efforts.
Investors and interested parties may access the webcast in the Investor
Events section of the Company's website, www.astx.com.
A webcast replay will be available for 90 days following the live event.
About Astex Pharmaceuticals
Astex Pharmaceuticals is dedicated to the discovery and development of
novel small molecule therapeutics with a focus on oncology. The Company
is developing a proprietary pipeline of novel therapies and is creating
de-risked products for partnership with leading pharmaceutical
companies. Astex Pharmaceuticals developed Dacogen® (decitabine) for
Injection and receives significant royalties on global sales.
For more information about Astex Pharmaceuticals, Inc., please visit http://www.astx.com.
Astex Pharmaceuticals, Inc.
Timothy L. Enns, 925-560-2810
Senior
Vice President
Corporate Communications & Marketing
tim.enns@astx.com
Susanna
Chau, 925-560-2845
Manager
Investor Relations
susanna.chau@astx.com
or
The
Trout Group
Alan Roemer, 646-378-2945
Managing Director
aroemer@troutgroup.com
or
College
Hill
Melanie Toyne-Sewell (Europe), +44 20 7866 7866
Rebecca
Skye Dietrich (US), 857-241-0795
astex@collegehill.com
Source: Astex Pharmaceuticals, Inc.
News Provided by Acquire Media
Close window | Back to top
Delicious
Digg
Facebook
LinkedIn
Twitter
Mixx
Yahoo! Buzz